Učitavanje...
Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
Pulmonary arterial hypertension, a disease largely neglected until a few decades ago, is presently the object of intense studies by several research teams. Despite considerable progress, pulmonary arterial hypertension remains a major clinical problem, because it is not always easy to diagnose, trea...
Spremljeno u:
| Izdano u: | Vasc Health Risk Manag |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6174907/ https://ncbi.nlm.nih.gov/pubmed/30323613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S133921 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|